-
Motilal Oswal is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 2140 in its research report dated July 24, 2025.
-
The company’s gross premium income for the quarter stood at Rs 17,178.5 crore, marking a 14 percent increase over Rs 15,105.5 crore recorded in Q1 FY25
-
HDFC Life has the most balanced product mix, ICICI Pru has the most diversified distribution mix, and SBI Life has the lowest cost structure
-
Motilal Oswal is bullish on SBI Life Insurance recommended buy rating on the stock with a target price of Rs 2000 in its research report dated April 24, 2025.
-
The solvency ratio stood at 1.96x as at March 31, 2025, matching regulatory requirements, while the expense management ratio was 8.40 percent in Q4
-
SBI Life continues to maintain its leadership position among private life insurers
-
Today, several major stocks are in focus, including UPL, SBI Life Insurance, ONGC, NTPC, and Shree Cement. UPL announced a significant investment of $53.85 million by its subsidiary, UPL Holdings Brazil, increasing its stake in Sinova Inovações Agrícolas S.A. to 49.97%. SBI Life Insurance appointed Dorababu Daparti as its new Deputy CEO to strengthen its leadership. Meanwhile, ONGC will invest Rs 1,200 crore in ONGC Green (OGL) through a rights issue to acquire a 100% stake in PTC Energy, marking a move towards green energy. NTPC and its subsidiary NTPC Green Energy signed MoUs with the Madhya Pradesh government for over Rs 2 lakh crore in renewable energy projects. Finally, Shree Cement faces a GST demand order of Rs 41.1 crore related to valuation and excess ITC claimed, which could affect its financials.
-
Motilal Oswal is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated January 18, 2025.
-
Shifting from a formidable parent support to agents for more business is commendable but filled with challenges.
-
Given favorable valuations and improved growth visibility, brokerages upgraded their ratings on SBI Life, while also hiking their target prices on the stock.
-
There are several positives that make the insurance stock a compelling choice
-
Motilal Oswal is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 2100 in its research report dated October 23, 2024.
-
Motilal Oswal is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated July 24, 2024.
-
Motilal Oswal is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated April 26, 2024.
-
Investors will watch the management’s commentary on VNB margin, changes in product mix, and growth guidance
-
Price for SBI LIFE Insurance forms a bullish piercing pattern at the support of rising trendline
-
Motilal Oswal is bullish on SBI Life Insurance recommended buy rating on the stock with a target price of Rs 1700 in its research report dated January 25, 2024.
-
SBI Life is best paced given the strong distribution footprint of its parent, lower cost ratios, higher margins, and strong business growth.
-
Brokerages estimate SBI Life's annual premium equivalent (APE) to come at Rs 5,963 crore in Q3FY24, while value of new business (VNB) is expected to be at Rs 1,702 crore
-
Strong distribution network to support the growth of the private life insurer
-
Brokerages are optimistic on the company due to healthy premium growth, price competitiveness, low cost ratios and superior agency strength.
-
Surrender value is the total payout that an insurance company gives the policyholder in case of pre-mature discontinuation of policies. Surrender charge is what the insurer charges from the policyholder
-
Looking at the implied earnings growth in the Nifty 50 index, stocks seem to be skewed towards overvaluation. About two-third of the stocks in the 50 Nifty basket are implying a growth rate of above 12 percent, the nominal GDP growth India is capable of with a real GDP growth of 8 percent and 4 percent inflation target
-
About 1948 shares advanced, 1649 shares declined, and 118 shares unchanged.
-
The net premium income of the insurer came in at Rs 16,260 crore, in H1FY24 up 24 percent from Rs 13,090 crore in the year-ago.
